DOCSLIB.ORG

Hazardous Substances (Chemicals) Transfer Notice 2006

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

16551655 OF THURSDAY, 22 JUNE 2006 WELLINGTON: WEDNESDAY, 28 JUNE 2006 — ISSUE NO. 72 ENVIRONMENTAL RISK MANAGEMENT AUTHORITY HAZARDOUS SUBSTANCES (CHEMICALS) TRANSFER NOTICE 2006 PURSUANT TO THE HAZARDOUS SUBSTANCES AND NEW ORGANISMS ACT 1996 1656 NEW ZEALAND GAZETTE, No. 72 28 JUNE 2006 Hazardous Substances and New Organisms Act 1996 Hazardous Substances (Chemicals) Transfer Notice 2006 Pursuant to section 160A of the Hazardous Substances and New Organisms Act 1996 (in this notice referred to as the Act), the Environmental Risk Management Authority gives the following notice. Contents 1 Title 2 Commencement 3 Interpretation 4 Deemed assessment and approval 5 Deemed hazard classification 6 Application of controls and changes to controls 7 Other obligations and restrictions 8 Exposure limits Schedule 1 List of substances to be transferred Schedule 2 Changes to controls Schedule 3 New controls Schedule 4 Transitional controls ______________________________ 1 Title This notice is the Hazardous Substances (Chemicals) Transfer Notice 2006. 2 Commencement This notice comes into force on 1 July 2006. 3 Interpretation In this notice, unless the context otherwise requires,— (a) words and phrases have the meanings given to them in the Act and in regulations made under the Act; and (b) the following words and phrases have the following meanings: 28 JUNE 2006 NEW ZEALAND GAZETTE, No. 72 1657 manufacture has the meaning given to it in the Act, and for the avoidance of doubt includes formulation of other hazardous substances pesticide includes but is not limited to, a product intended for use as an acaricide, antifouling paint, antisapstain, avicide, fumigant, fungicide, insecticide, herbicide, miticide, molluscicide, piscicide, timber treatment preservative or vertebrate toxic agent UN Model Regulations means the 14th revised edition of the Recommendation on the Transport of Dangerous Goods Model Regulations, published in 2005 by the United Nations variation code, in relation to a substance described in Schedule 1, means a number set out in the column entitled “variation code(s)” opposite the description of the substance in Schedule 1 veterinary medicine has the same meaning given to it in the Agricultural Compounds and Veterinary Medicines Act 1997 4 Deemed assessment and approval (1) On the commencement of this notice, the hazardous substances described in Schedule 1 are no longer subject to the provisions of Parts 11 to 15 of the Act. (2) Each hazardous substance described in Schedule 1 is deemed to have been assessed and approved by the Authority under section 29 of the Act. 5 Deemed hazard classification Each hazardous substance described in Schedule 1 is deemed to have the hazard classifications specified opposite its description in Schedule 1. 6 Application of controls and changes to controls (1) The controls that apply to the hazardous substances described in Schedule 1 are as follows: (a) the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001, with the changes indicated in Schedule 2: (b) the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001, with the changes indicated in Schedule 2: (c) the Hazardous Substances (Packaging) Regulations 2001, with the changes indicated in Schedule 2: (d) the Hazardous Substances (Disposal) Regulations 2001, with the changes indicated in Schedule 2: (e) the Hazardous Substances (Tracking) Regulations 2001, with the changes indicated in Schedule 2: (f) the Hazardous Substances and New Organisms (Personnel Qualifications) Regulations 2001: 1658 NEW ZEALAND GAZETTE, No. 72 28 JUNE 2006 (g) the Hazardous Substances (Emergency Management) Regulations 2001, with the changes indicated in Schedule 2: (h) the Hazardous Substances (Identification) Regulations 2001, with the changes indicated in Schedule 2: (i) the Hazardous Substances (Compressed Gases) Regulations 2004: (j) the Hazardous Substances (Tank Wagon and Transportable Containers) Regulations 2004: (k) the controls for stationary container systems set out in Schedule 8 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (New Zealand Gazette, 2004, No. 35, p 767), with the changes indicated in Schedule 2 to this notice: (l) the controls for secondary containment set out in Schedule 9 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (New Zealand Gazette, 2004, No. 35, p 767), with the changes indicated in Schedule 2 to this notice: (m) the controls for the adverse effects of unintended ignition of class 2 and class 3.1 hazardous substances set out in Schedule 10 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004 (New Zealand Gazette, 2004, No. 35 p 767), with the changes indicated in Schedule 2 to this notice. (2) Subclause (1)(k) applies despite clause 1(1) of Schedule 8 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004. (3) Subclause (1)(l) applies despite clause 1(1) of Schedule 9 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004. (4) Subclause (1)(m) applies despite clause 1 of Schedule 10 to the Hazardous Substances (Dangerous Goods and Scheduled Toxic Substances) Transfer Notice 2004. 7 Other obligations and restrictions The obligations and restrictions specified in Schedule 3 and Schedule 4 are imposed as controls under section 160B of the Act applying to the hazardous substances described in Schedule 1. 28 JUNE 2006 NEW ZEALAND GAZETTE, No. 72 1659 8 Exposure limits (1) Exposure limits are adopted for a hazardous substance described in Schedule 1 (or any component of the substance) to the extent (if at all) that they are set out on the register of exposure limits. (2) In the case of workplace exposure standard values, where a WES value does not exist on the register of exposure limits but is listed in the document referred to in subclause (3), the value or values specified in that document shall apply to the substance or any component of the substance. (3) The document referred to in subclause (2) is the document entitled “Workplace Exposure Standards”, published by the Occupational Safety and Health Service, Department of Labour, January 2002, ISBN 0-477-03660-0. 1660 NEW ZEALAND GAZETTE, No. 72 28 JUNE 2006 Schedule 1 List of substances to be transferred Explanatory notes to Schedule 1: These notes are not part of the notice, but are intended to assist in understanding its scheme. Substances are listed in the following tables in alphabetical order. Table 1 Pesticide, veterinary medicine and pharmaceutical actives Table 2 Gases that are hazardous substances Table 3 Ethanol dilutions Table 4 Chemicals Variation codes 1 to 3 relate to a change to regulation 9 (approved handler requirements) of the Hazardous Substances (Classes 1 to 5 Controls) Regulations 2001. Variation codes 4 to 10 relate to a change to regulation 9 (approved handler requirements) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001. Variation code 11 relates to a change to regulation 32 (environmental exposure limits) of the Hazardous Substances (Classes 6, 8, and 9 Controls) Regulations 2001. Variation codes 12 to 16 relate to changes to regulation 19 (packaging requirements for toxic substances) of the Hazardous Substances (Packaging) Regulations) 2001. Variation codes 17 and 18 relate to changes to regulations 36 (secondary containment), 37 and 38 (surface containers) of the Hazardous Substances (Emergency Management) Regulations 2001. Variation codes 19 relates to a change to regulations 4 to 6 (records and transfer of tracked substances) of the Hazardous Substances (Tracking) Regulations 2001. Variation codes 20 and 21 relate to specification of pesticide, veterinary medicine and pharmaceutical actives. 28 JUNE 2006 NEW ZEALAND GAZETTE, No. 72 1661 Table 1 Pesticide, veterinary medicine and pharmaceutical actives Substance Name CAS Number Hazard Classification(s) Variation Code(s) 1,3,5-Triazine-2,4-diamine, N-ethyl-N'- 834-12-8 6.1D, 6.4A, 6.9B, 9.1A, 9.3C 4, 11, 19, 21 (1-methylethyl)-6-(methylthio)- 1,4-Dimethylnaphthalene 571-58-4 6.1E, 6.3A, 6.4A, 9.1A 4, 11, 17, 18, 19, 21 1H-Pyrrole-3-carbonitrile, 4-bromo-2- 122454-29-9 6.1B, 9.1A, 9.3A, 9.4B 5, 9, 11, 21 (4-chlorophenyl)-5- 2-(Thiocyanomethylthio) benzothiazole 21564-17-0 6.1B, 6.3A, 6.5B, 6.9B, 5, 9, 11, 14, 17, 18, 8.3A, 9.1A, 9.3C 21 2,4-D 94-75-7 6.1C, 6.3A, 6.4A, 6.5B, 8, 11, 19, 21 6.9A, 9.1B, 9.2A, 9.3B 2,4-D amine salt 2008-39-1 6.1D, 6.3B, 6.4A, 6.5B, 4, 11, 19, 21 6.9A, 9.1A, 9.2A, 9.3B 2,4-D butyl ester 94-80-4 6.1D, 6.3B, 6.4A, 6.5B, 4, 11, 19, 21 6.9A, 9.1A, 9.2A, 9.3C 2,4-D ethyl hexyl ester 1928-43-4 6.1D, 6.5B, 6.9A, 9.1A, 4, 11, 19, 21 9.2A, 9.3C 4,6-Dinitro-o-cresol 534-52-1 6.1B, 6.3A, 6.5B, 6.6B, 5, 9, 11, 21 8.3A, 9.1A 4-Aminopyridine 504-24-5 6.1A, 6.3A, 6.4A, 9.1B, 9.3A 5, 9, 11, 21 5-Pyrimidinemethanol, .alpha.-(1- 56425-91-3 6.1D, 9.3B 11, 21 methylethyl)-.alpha.-[4- (trifluoromethoxy)phenyl]- Abamectin 71751-41-2 6.1B, 6.8B, 6.8C, 6.9A, 5, 9, 10, 11, 20 9.1A, 9.2A, 9.3A, 9.4A Acebutolol hydrochloride 34381-68-5 6.3A, 6.4A, 6.5A, 6.5B, 6.9B 16 Acephate 30560-19-1 6.1D, 6.7B, 6.8B, 6.9A, 4, 11, 16, 19, 21 9.1D, 9.3B, 9.4A Acetamiprid 135410-20-7 6.1C, 6.9B, 9.1A, 9.2B, 9.3B, 8, 11, 19, 21 9.4B Acetochlor 34256-82-1 6.1D, 6.3A, 6.5B, 6.9B, 4, 11, 17, 18, 19, 21 9.1A, 9.2A, 9.3C Acetylsalicylic acid 50-78-2 6.1C, 6.3B, 6.4A, 9.3B 8, 11, 19, 20 Actinomycin C 8052-16-2 6.1B, 9.3A 5, 9, 11 Actinomycin D 50-76-0 6.1A, 6.4A, 9.3A 5, 9, 11 Acyclovir 59277-89-3 6.1D, 6.5A, 6.5B, 9.3C 11, 16 Alachlor 15972-60-8 6.1D, 6.4A, 6.5B, 6.7B, 4, 11, 19, 21 6.9A, 9.1A, 9.2A, 9.3C Albendazole 54965-21-8 6.1D, 6.5B, 6.6B, 6.8A, 11, 16, 20 6.9B, 9.3C Allethrin 584-79-2 3.1D, 6.1C, 6.3B, 6.4A, 8, 11, 17, 19, 21 6.9B, 9.1A, 9.3B, 9.4B Allopurinol 315-30-0 6.1D, 6.5B, 6.9B, 9.3C 11 alpha-Cypermethrin 67375-30-8 6.1B, 6.9B, 9.1A, 9.3B, 9.4A 5, 9, 11, 21 Amiloride hydrochloride 17440-83-4 6.1C, 6.5A, 6.5B, 9.3B 8, 11, 19 Aminophylline 317-34-0 6.1C, 6.3A, 6.9B, 8.3A, 9.3B 8, 11, 19 1662 NEW ZEALAND GAZETTE, No.
Recommended publications
  • EPA Handbook: Optical and Remote Sensing for Measurement and Monitoring of Emissions Flux of Gases and Particulate Matter

    EPA Handbook: Optical and Remote Sensing for Measurement and Monitoring of Emissions Flux of Gases and Particulate Matter

    EPA Handbook: Optical and Remote Sensing for Measurement and Monitoring of Emissions Flux of Gases and Particulate Matter EPA 454/B-18-008 August 2018 EPA Handbook: Optical and Remote Sensing for Measurement and Monitoring of Emissions Flux of Gases and Particulate Matter U.S. Environmental Protection Agency Office of Air Quality Planning and Standards Air Quality Assessment Division Research Triangle Park, NC EPA Handbook: Optical and Remote Sensing for Measurement and Monitoring of Emissions Flux of Gases and Particulate Matter 9/1/2018 Informational Document This informational document describes the emerging technologies that can measure and/or identify pollutants using state of the science techniques Forward Optical Remote Sensing (ORS) technologies have been available since the late 1980s. In the early days of this technology, there were many who saw the potential of these new instruments for environmental measurements and how this technology could be integrated into emissions and ambient air monitoring for the measurement of flux. However, the monitoring community did not embrace ORS as quickly as anticipated. Several factors contributing to delayed ORS use were: • Cost: The cost of these instruments made it prohibitive to purchase, operate and maintain. • Utility: Since these instruments were perceived as “black boxes.” Many instrument specialists were wary of how they worked and how the instruments generated the values. • Ease of use: Many of the early instruments required a well-trained spectroscopist who would have to spend a large amount of time to setup, operate, collect, validate and verify the data. • Data Utilization: Results from path integrated units were different from point source data which presented challenges for data use and interpretation.
  • Transport of Dangerous Goods

    Transport of Dangerous Goods

    ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions.
  • United States Patent (19) (11) 4,161,571 Yasui Et Al

    United States Patent (19) (11) 4,161,571 Yasui Et Al

    United States Patent (19) (11) 4,161,571 Yasui et al. 45 Jul. 17, 1979 (54) PROCESS FOR PRODUCTION OF THE 4,080,493 3/1978 Yasui et al. .......................... 260/879 MALE CANHYDRDE ADDUCT OF A 4,082,817 4/1978 Imaizumi et al. ...................... 526/46 LIQUID POLYMER 4,091,198 5/1978 Smith ..................................... 526/56 75 Inventors: Seimei Yasui, Takarazuka; Takao FOREIGN PATENT DOCUMENTS Oshima, Sonehigashi, both of Japan 2262677 2/1975 France ....................................... 526/56 73) Assignee: Sumitomo Chemical Company, 44-1989 1/1969 Japan ......................................... 526/56 Limited, Osaka, Japan Primary Examiner-William F. Hamrock Attorney, Agent, or Firm-Birch, Stewart, Kolasch and 21 Appl. No.: 843,311 Birch 22 Filed: Oct. 18, 1977 57 ABSTRACT Related U.S. Application Data A process for production of the maleic anhydride ad duct of a liquid polymer having a maleic anhydride 62 Division of Ser. No. 733,914, Oct. 19, 1976, Pat, No. addition amount of 2 to 70% by weight, which com 4,080,493. prises reacting a liquid polymer having a molecular 51 Int. C.’................................................ CO8F 8/46 weight of 150 to 5,000 and a viscosity of 2 to 50,000 cp (52) U.S. C. ...................................... 526/90; 526/192; at 30 C. in the presence of at least one compound, as a 526/209; 526/213; 526/193; 526/195; 526/226; gelation inhibitor, selected from the group consisting of 526/233; 526/237; 526/238; 526/272; 525/285; imidazoles, thiazoles, metallic salts of mercapto 525/249; 525/251; 525/255; 525/245; 525/248 thiazoles, urea derivatives, naphthylamines, nitrosa (58) Field of Search ................
  • Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds

    Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds

    Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Library Listing – 1,523 spectra Subset of Aldrich FT-IR Library related to organometallic, inorganic, boron and deueterium compounds. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collections of FT-IR Spectra Editions I or II, and the data has been carefully examined and processed by Thermo Fisher Scientific. Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 1066 ((R)-(+)-2,2'- 1193 (1,2- BIS(DIPHENYLPHOSPHINO)-1,1'- BIS(DIPHENYLPHOSPHINO)ETHAN BINAPH)(1,5-CYCLOOCTADIENE) E)TUNGSTEN TETRACARBONYL, 1068 ((R)-(+)-2,2'- 97% BIS(DIPHENYLPHOSPHINO)-1,1'- 1062 (1,3- BINAPHTHYL)PALLADIUM(II) CH BIS(DIPHENYLPHOSPHINO)PROPA 1067 ((S)-(-)-2,2'- NE)DICHLORONICKEL(II) BIS(DIPHENYLPHOSPHINO)-1,1'- 598 (1,3-DIOXAN-2- BINAPH)(1,5-CYCLOOCTADIENE) YLETHYNYL)TRIMETHYLSILANE, 1140 (+)-(S)-1-((R)-2- 96% (DIPHENYLPHOSPHINO)FERROCE 1063 (1,4- NYL)ETHYL METHYL ETHER, 98 BIS(DIPHENYLPHOSPHINO)BUTAN 1146 (+)-(S)-N,N-DIMETHYL-1-((R)-1',2- E)(1,5- BIS(DI- CYCLOOCTADIENE)RHODIUM(I) PHENYLPHOSPHINO)FERROCENY TET L)E 951 (1,5-CYCLOOCTADIENE)(2,4- 1142 (+)-(S)-N,N-DIMETHYL-1-((R)-2- PENTANEDIONATO)RHODIUM(I), (DIPHENYLPHOSPHINO)FERROCE 99% NYL)ETHYLAMIN 1033 (1,5- 407 (+)-3',5'-O-(1,1,3,3- CYCLOOCTADIENE)BIS(METHYLD TETRAISOPROPYL-1,3- IPHENYLPHOSPHINE)IRIDIUM(I)
  • Ep 2508506 A1

    Ep 2508506 A1

    (19) & (11) EP 2 508 506 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 10.10.2012 Bulletin 2012/41 C07C 67/343 (2006.01) C07C 227/08 (2006.01) C07F 5/02 (2006.01) C07C 229/34 (2006.01) (21) Application number: 11161611.6 (22) Date of filing: 08.04.2011 (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AL AT BE BG CH CY CZ DE DK EE ES FI FR GB yet been filed GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: Kunic Tesovic, Barbara Designated Extension States: Lek Pharmaceuticals d.d. BA ME Sandoz Development Center Slovenia - Patents Verovskova 57 (71) Applicant: LEK Pharmaceuticals d.d. 1526 Ljubljana (SI) 1526 Ljubljana (SI) (54) Preparation of sitagliptin intermediates (57) The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin. EP 2 508 506 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 508 506 A1 Description Field of the Intention 5 [0001] The present invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin. Background prior art 10 [0002] Type II diabetes mellitus (T2DM) is a global epidemic. Therefore, the research is oriented in the development of selective inhibitors of the enzyme DPP-IV as a promising new treatment for the type II diabetes.
  • The Synthesis of 1,2-Azaphospholes, 1,2-Azaphosphorines and 1,2-Azaphosphepines

    The Synthesis of 1,2-Azaphospholes, 1,2-Azaphosphorines and 1,2-Azaphosphepines

    The Free Internet Journal Review for Organic Chemistry Archive for Arkivoc 2020, i, 472-498 Organic Chemistry The synthesis of 1,2-azaphospholes, 1,2-azaphosphorines and 1,2-azaphosphepines Noha M. Hassanin,a Tarik E. Ali,b,a* Mohammed A. Assiri,b Hafez M. Elshaaer,a and Somaia M. Abdel-Kariema a Department of Chemistry, Faculty of Education, Ain Shams University, Roxy, Cairo, Egypt b Department of Chemistry, Faculty of Science, King Khalid University, Abha, Saudi Arabia Email: [email protected], [email protected] Received 06-28-2020 Accepted 08-26-2020 Published online 10-22-2020 Abstract 1,2-Azaphospholes, 1,2-azaphosphorines and 1,2-azaphosphepines are prominent phosphorus heterocycles and are of interest due to their potent pharmacological activities. In this review, we provide the available literature data on the synthesis of 1,2-azaphospholes, 1,2-azaphosphorines and 1,2-azaphosphepines. Keywords: 1,2-azaphospholes, 1,2-azaphosphorines, 1,2-azaphosphepines, phosphorus heterocycles DOI: https://doi.org/10.24820/ark.5550190.p011.280 Page 472 ©AUTHOR(S) Arkivoc 2020, i, 472-498 Hassanin, N. M. et al. Table of Contents 1. Introduction 2. Synthetic Methods for Functionalized 1,2-Azaphosphole Derivatives 2.1 Cyclization of ethyl N-methyl-3-bromopropylphosphonamidate with NaH 2.2 Cyclization of -aminophosphorus compounds with bases 2.3 Reaction of methyleneaminophosphanes with activated alkenes and alkynes 2.4 Cyclization of 2-[2-(t-butylimino)cyclohexyl]acetonitrile with PCl3 2.5 Cyclization of 2-imino-2H-chromene-3-carboxamide
  • Synthesis of C2-Symmetric P-Chiral Bis(Phosphine Borane)

    Synthesis of C2-Symmetric P-Chiral Bis(Phosphine Borane)

    Synthesis of C2-symmetric P-chiral bis(phosphine borane)s and their application in rhodium(I) catalyzed asymmetric transformation by Holly Ann Heath A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry Montana State University © Copyright by Holly Ann Heath (2001) Abstract: A new development for the synthesis C2-Synnnetric P-Chiral Bis(phosphine borane) ligands is reported, These ligands are based on the asymmetric induction of prochiral phosphine ligands with organolithium/chiral diamine complexes. These ligands have been evaluated in asymmetric rhodium(I) catalyzed hydrogenation and [4 + 2] cycloisomerization reactions. Enantiomeric excesses as high as 99% were obtained for ene-diene cycloadditions. Synthesis of C2-Symmetric P-Chiral Bis(phosphine borane)s and Their Application in Rhodium(I) Catalyzed Asymmetric Transformation by Holly Ann Heath A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry Montana State University Bozeman, Montana March 2001 ii APPROVAL of a dissertation submitted by Holly Ann Heath This dissertation has been read by each member of the dissertation committee and has been found to be satisfactory regarding content, English usage, format, citations, bibliographic style, and consistency, and is ready for submission to the College of Graduate Studies. Dr. Thomas Livinghouse < Chairperson, Graduate Committee Date Approved for the Department of Chemistry Dr. Paul A. Grieco Department Head Approved for the College of Graduate Studies Dr. Bruce R. McLeod Graduate Dean Date iii STATEMENT OF PERMISSION TO USE In presenting this dissertation .in partial fulfillment of the requirements for a doctoral degree at Montana State University-Bozeman, I agree that the Library shall make it available to borrowers under rules of the Library.
  • Alphabetical Index of Substances and Articles

    Alphabetical Index of Substances and Articles

    ALPHABETICAL INDEX OF SUBSTANCES AND ARTICLES - 355 - NOTES TO THE INDEX 1. This index is an alphabetical list of the substances and articles which are listed in numerical order in the Dangerous Goods List in Chapter 3.2. 2. For the purpose of determining the alphabetical order the following information has been ignored even when it forms part of the proper shipping name: numbers; Greek letters; the abbreviations “sec” and “tert”; and the letters “N” (nitrogen), “n” (normal), “o” (ortho) “m” (meta), “p” (para) and “N.O.S.” (not otherwise specified). 3. The name of a substance or article in block capital letters indicates a proper shipping name. 4. The name of a substance or article in block capital letters followed by the word “see” indicates an alternative proper shipping name or part of a proper shipping name (except for PCBs). 5. An entry in lower case letters followed by the word “see” indicates that the entry is not a proper shipping name; it is a synonym. 6. Where an entry is partly in block capital letters and partly in lower case letters, the latter part is considered not to be part of the proper shipping name. 7. A proper shipping name may be used in the singular or plural, as appropriate, for the purposes of documentation and package marking. - 356 - INDEX Name and description Class UN No. Name and description Class UN No. Accumulators, electric, see 4.3 3292 Acid mixture, nitrating acid, see 8 1796 8 2794 8 2795 Acid mixture, spent, nitrating acid, see 8 1826 8 2800 8 3028 Acraldehyde, inhibited, see 6.1 1092 ACETAL 3 1088
  • Hexafluorosilicic Acid

    Hexafluorosilicic Acid

    Sodium Hexafluorosilicate [CASRN 16893-85-9] and Fluorosilicic Acid [CASRN 16961-83-4] Review of Toxicological Literature October 2001 Sodium Hexafluorosilicate [CASRN 16893-85-9] and Fluorosilicic Acid [CASRN 16961-83-4] Review of Toxicological Literature Prepared for Scott Masten, Ph.D. National Institute of Environmental Health Sciences P.O. Box 12233 Research Triangle Park, North Carolina 27709 Contract No. N01-ES-65402 Submitted by Karen E. Haneke, M.S. (Principal Investigator) Bonnie L. Carson, M.S. (Co-Principal Investigator) Integrated Laboratory Systems P.O. Box 13501 Research Triangle Park, North Carolina 27709 October 2001 Toxicological Summary for Sodium Hexafluorosilicate [16893-85-9] and Fluorosilicic Acid [16961-83-4] 10/01 Executive Summary Nomination Sodium hexafluorosilicate and fluorosilicic acid were nominated for toxicological testing based on their widespread use in water fluoridation and concerns that if they are not completely dissociated to silica and fluoride in water that persons drinking fluoridated water may be exposed to compounds that have not been thoroughly tested for toxicity. Nontoxicological Data Analysis and Physical-Chemical Properties Analytical methods for sodium hexafluorosilicate include the lead chlorofluoride method (for total fluorine) and an ion-specific electrode procedure. The percentage of fluorosilicic acid content for water supply service application can be determined by the specific-gravity method and the hydrogen titration method. The American Water Works Association (AWWA) has specified that fluorosilicic acid contain 20 to 30% active ingredient, a maximum of 1% hydrofluoric acid, a maximum of 200 mg/kg heavy metals (as lead), and no amounts of soluble mineral or organic substance capable of causing health effects.
  • Simultaneous Determination of Some Antiprotozoal Drugs in Different

    Simultaneous Determination of Some Antiprotozoal Drugs in Different

    Abdelaleem and Abdelwahab Chemistry Central Journal 2012, 6:27 http://journal.chemistrycentral.com/content/6/1/27 RESEARCHARTICLE Open Access Simultaneous determination of some antiprotozoal drugs in different combined dosage forms by mean centering of ratio spectra and multivariate calibration with model updating methods Eglal A Abdelaleem and Nada S Abdelwahab* Abstract Background: Metronidazole (MET) and Diloxanide Furoate (DF), act as antiprotozoal drugs, in their ternary mixtures with Mebeverine HCl (MEH), an effective antispasmodic drug. This work concerns with the development and validation of two simple, specific and cost effective methods mainly for simultaneous determination of the proposed ternary mixture. In addition, the developed multivariate calibration model has been updated to determine Metronidazole benzoate (METB) in its binary mixture with DF in Dimetrol® suspension. Results: Method (I) is the mean centering of ratio spectra spectrophotometric method (MCR) that depends on using the mean centered ratio spectra in two successive steps that eliminates the derivative steps and therefore the signal to noise ratio is enhanced. The developed MCR method has been successfully applied for determination of MET, DF and MEH in different laboratory prepared mixtures and in tablets. Method (II) is the partial least square (PLS) multivariate calibration method that has been optimized for determination of MET, DF and MEH in Dimetrol ® tablets and by updating the developed model, it has been successfully used for prediction of binary mixtures of DF and Metronidazole Benzoate ester (METB) in Dimetrol ® suspension with good accuracy and precision without reconstruction of the calibration set. Conclusion: The developed methods have been validated; accuracy, precision and specificity were found to be within the acceptable limits.
  • Nomination Background: Methyl Trans

    Nomination Background: Methyl Trans

    ' 7/?1 Methyl styryl ketone 122-57-6 NTP NOMINATION HISTORY AND REVIEW A. Nomination History 1. Nomination Source: NCI 2. Recommendations: -Comparative toxicity studies with methyl vinyl ketone -Metabolism -Carcinogenicity 3. Rationale/Remarks: -Potential for widespread human exposure -Nominated as a result of a class study of a,~-unsaturated ketones -Flavoring and fragrance additive -Natural product -Environmental pollutant -Mutagenic in Salmonella 4. Priority: -High for toxicity studies -Moderate for carcinogenicity s. Date of Nomination: July 1994 B. Interagency Committee for Chemical Evaluation and Coordination Review 1. Date of Review: 2. Recommendations: 3. Priority: 4. NTP Chemical Selection Principles: 5. Rationale/Remarks: 122-57-6 Methyl styryl ketone SUMMARY OF DATA FOR CHEMICAL SELECTION CHEMICAL IDENTIFICATION CAS Registry Number: 122-57-6 Chemical Abstracts Name: 3-Buten-2-one, 4-phenyl- (SCI, 9CI) Svnonvms and Trade Names: Acetocinnamone; benzalacetone; benzylideneacetone; methyl 2­ phenylvinyl ketone; methyl styryl ketone; methyl ~-styryl ketone; 4­ phenylbutenone; 4-phenyl-3-butene-2-one; 2-phenylvinyl methyl ketone; styryl methyl ketone; MSK FEMA Number: 2881 Related isomers CAS Registry Number: 937-53-1 Chemica] Abstracts Name: 3-Buten-2-one, 4-phenyl-, (Z)- (SCI, 9CI) Synonvms and Trade Names: cis -4-Phenyl-3-buten-2-one; cis -benzalacetone; cis­ benzylideneacetone; cis-methyl styryl ketone CAS Registry Number: 1896-62-4 Chemical Abstracts Name: 3-Buten-2-one, 4-phenyl-, (E)- (SCI, 9CI) Synonyms and Trade Names: trans-4-Phenyl-3-buten-2-one; trans-benzalacetone; trans­ benzylideneacetone; trans-methyl styryl ketone; TPBO Structure. Molecular Formula. and Molecular WeiKbt 0 II H•CHCCH3 Mol. wt.: 146.19 Chemical and Phvsical Properties (from Aldrich Chemical Co., 1993, 1994; Budavari, 1989) Description: White to yellow solid with a sweet, pungent, creamy, floral odor Prepared for NCI by Technical Resources, Inc.
  • Economic Commission for Europe Inland Transport

    Economic Commission for Europe Inland Transport

    ECONOMIC COMMISSION FOR EUROPE INLAND TRANSPORT COMMITTEE INF.6 Working Party on the Transport of Dangerous Goods Joint Meeting of the RID Safety Committee and the Working Party on the Transport of Dangerous Goods (Geneva, 1-10 September 2003) Harmonization with the UN Recommendations on the Transport of Dangerous Goods Bulk containers Transmitted by the Government of the United Kingdom 1. Introduction New provisions for bulk containers from the UN Model Regulations are being proposed for inclusion in RID/ADR based on text prepared by the UN Secretariat and as discussed at the ad hoc Working Group on the Harmonization of RID/ADR/ADN with the UN Recommendations on the Transport of Dangerous Goods that met from 26-28 May 2003. The results of the discussions on this subject are recorded in paragraphs 39 to 46 of the report of the ad hoc Working Group TRANS/WP.15/AC.1/2003/56 and the proposed text for inclusion in RID/ADR in the relevant parts of Addendum 1 to 7 of 2003/56, in particular a new chapter 6.11 and a modified chapter 7.3. 2. Proposal and Justification A new chapter 6.11, reflecting UN chapter 6.8, is contained in 2003/56 Add 6 dealing with the requirements for the design, construction, inspection and testing of bulk containers and new UN chapter 4.3 dealing with the use of bulk containers has been integrated into a modified chapter 7.3 contained in 2003/56 Add 7. Now that there are comprehensive provisions for bulk containers developed at UN level, the UK believes as reflected in paragraph 43 of 2003/56, that these should now apply to carriage in bulk in RID/ADR rather than have two separate systems based on the provisions for bulk containers in UN and the existing provisions in RID/ADR.